Brachytherapy
Volume 5, Issue 4 , Pages 230-234 , October 2006

Evaluation of the surface radiation dose and dose gradient in early stage breast cancer using high-dose-rate brachytherapy MammoSite™ applicator

  • Amir Sadeghi

      Affiliations

    • Texas Cancer Clinic, San Antonio, TX
    • Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX
    • Corresponding Author InformationCorresponding author. Texas Cancer Clinic, 9102 Floyd Curl, San Antonio, TX 78240. Tel.: +1-210-317-2320; fax: +1-210-558-0758.
    • ,
  • Bradley Prestidge

      Affiliations

    • Texas Cancer Clinic, San Antonio, TX
    • Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX
    • ,
  • Jui-Min Lee

      Affiliations

    • Department of Radiology, University of Texas Health Science Center at San Antonio, San Antonio, TX
    • ,
  • Arthur Rosenthal

      Affiliations

    • Department of Surgery, Southwest Texas Methodist Hospital, San Antonio, TX

Received 9 December 2005 ,Revised 23 January 2006 ,Accepted 3 February 2006.

References 

  1. Bilchert-Toft M, Rose C, Anderson JA, et al. Danish randomized trial comparing breast conservation therapy with mastectomy: Six years of life-table analysis. J Natl Cancer Inst Monogr. 1992;11:19–25
  2. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of followup in a randomized trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 1995;333:1456–1461
  3. Back NF, Morgan GW. The rate of breast conserving surgery in early breast cancer: An audit of surgical practice at St Vincent's campus, NSW in 1990 and 1994. Australas Radiol. 2000;44:60–64
  4. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year followup of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–1232
  5. Fisher B, Anderson S, Bryant J, et al. Twenty-year followup of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–1241
  6. Perera F, Engel J, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: A pilot study. J Surg Oncol. 1997;65:263–268
  7. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is, 1,2) breast cancer. Am J Surg. 2000;180:299–304
  8. Vicini FA, Baglan KL, Kestin LL, et al. Accelerated treatment of breast cancer. J Clin Oncol. 2001;19:1993–2001
  9. Polgar C, Sulyok Z, Fodor J, et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: Five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol. 2002;80:12–128
  10. Arthur D, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: Low-dose-rate and high-dose-rate experience. Int J Radiat Biol Phys. 2003;56:68–689
  11. Kuerer HM, Julian TB, Strom EA, et al. Accelerated partial breast irradiation after conservative surgery for breast cancer. Ann Surg. 2004;239:338–351
  12. Fentiman IS, Poole C, Tong D, et al. Inadequacy of iridium implant as sole radiation treatment for operable breast cancer. Eur J Cancer. 1996;32A(4):608–611
  13. Vicini FA, Kestin LL, Edmundson GK, et al. Dose-volume analysis for quality assurance of interstitial brachytherapy for breast cancer. Int J Radiat Oncol Biol Phys. 1999;45:803–810
  14. Weides CD, Mok EC, Chang WC, et al. Evaluating the dose to the contralateral breast when using a dynamic wedge versus a regular wedge. Med Dosim. 1995;20:287–293
  15. Kelly CA, Wang XY, Chu JC, et al. Dose to contralateral breast: A comparison of four primary breast irradiation techniques. Int J Radiat Oncol Biol Phys. 1996;34:727–732
  16. Keisch M, Vicini F, Kuske R, et al. Two-year outcome with the MammoSite™ breast brachytherapy applicator: Factors associated with optimal cosmetic outcome when performing partial breast irradiation. Int J Radiat Oncol Biol Phys. 2003;57:S311
  17. Richards GM, Berson AM, Rescigno J, et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite™ applicator in patients with early-stage breast cancer. Ann Surg Oncol. 2004;11:739–746
  18. Dickler A, Kirk MC, Choo J, et al. Cosmetic outcome and incidence of infection with the MammoSite™ breast brachytherapy applicator. Breast J. 2005;11:306–310
  19. Wazer DE, Lowthier D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early stage breast cancer. Int J Radiat Oncol Biol Phys. 2001;50:107–111

PII: S1538-4721(06)00247-9

doi: 10.1016/j.brachy.2006.02.004

Brachytherapy
Volume 5, Issue 4 , Pages 230-234 , October 2006

Article Tools

* Image Usage & Resolution